118 related articles for article (PubMed ID: 33908192)
1. Serum hypoxia-inducible factor-2: A candidate prognostic biomarker for laryngeal cancer.
Eskiizmir G; Çalıbaşı Koçal G; Uysal T; Ellidokuz H; Başpınar Y
Clin Otolaryngol; 2021 Nov; 46(6):1172-1183. PubMed ID: 33908192
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma.
Bernstein JM; Andrews TD; Slevin NJ; West CM; Homer JJ
Laryngoscope; 2015 Jan; 125(1):E8-15. PubMed ID: 25230150
[TBL] [Abstract][Full Text] [Related]
3. The evaluation of pretreatment neutrophil-lymphocyte ratio and derived neutrophil-lymphocyte ratio in patients with laryngeal neoplasms.
Eskiizmir G; Uz U; Onur E; Ozyurt B; Karaca Cikrikci G; Sahin N; Oran A; Celik O
Braz J Otorhinolaryngol; 2019; 85(5):578-587. PubMed ID: 29936214
[TBL] [Abstract][Full Text] [Related]
4. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis.
Starska K; Forma E; Jóźwiak P; Bryś M; Lewy-Trenda I; Brzezińska-Błaszczyk E; Krześlak A
Tumour Biol; 2015 Apr; 36(4):2309-21. PubMed ID: 25412955
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of serum HIF-1α change following transarterial chemoembolization in hepatocellular carcinoma.
Lin ZH; Jiang JR; Ma XK; Chen J; Li HP; Li X; Wu XY; Huang MS; Lin Q
Clin Exp Med; 2021 Feb; 21(1):109-120. PubMed ID: 33037574
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of recurrence for serum hypoxia inducible factor-1α C-reaction protein in hepatocellular carcinoma patients after transcatheter arterial chemoembolization.
Jing Q; Jianyong L; Jiming Y; Shuren L; Rui W; Wei L
Indian J Cancer; 2015 Dec; 52 Suppl 2():e105-6. PubMed ID: 26728665
[TBL] [Abstract][Full Text] [Related]
7. Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapy.
Douglas CM; Bernstein JM; Ormston VE; Hall RC; Merve A; Swindell R; Valentine HR; Slevin NJ; West CM; Homer JJ
Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):59-65. PubMed ID: 22841149
[TBL] [Abstract][Full Text] [Related]
8. The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.
Yang SL; Liu LP; Jiang JX; Xiong ZF; He QJ; Wu C
Jpn J Clin Oncol; 2014 Feb; 44(2):159-67. PubMed ID: 24374892
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; de Bock GH; Langendijk JA; Kluin PM; Schuuring E; van der Laan BF; van der Wal JE
Laryngoscope; 2013 Sep; 123(9):2154-60. PubMed ID: 24167820
[TBL] [Abstract][Full Text] [Related]
10. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between the expression of hypoxia-inducible factor-1alpha and epidermal growth factor receptor and micro vessel density and their clinical significance].
Lin P; Wang W; Cai WJ; Han CR; Sun Y; Li M; Sun BC
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun; 44(6):480-5. PubMed ID: 19954019
[TBL] [Abstract][Full Text] [Related]
13. Combined over-expression of the hypoxia-inducible factor 2α gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcoma.
Li W; He X; Xue R; Zhang Y; Zhang X; Lu J; Zhang Z; Xue L
Pathol Res Pract; 2016 Oct; 212(10):861-866. PubMed ID: 27623205
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1alpha and -2alpha are expressed in most rectal cancers but only hypoxia-inducible factor-1alpha is associated with prognosis.
Rasheed S; Harris AL; Tekkis PP; Turley H; Silver A; McDonald PJ; Talbot IC; Glynne-Jones R; Northover JM; Guenther T
Br J Cancer; 2009 May; 100(10):1666-73. PubMed ID: 19436307
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor 1α expression is a prognostic biomarker in patients with astrocytic tumors associated with necrosis on MR image.
Mashiko R; Takano S; Ishikawa E; Yamamoto T; Nakai K; Matsumura A
J Neurooncol; 2011 Mar; 102(1):43-50. PubMed ID: 20596750
[TBL] [Abstract][Full Text] [Related]
16. Association between serum concentrations of hypoxia inducible factor responsive proteins and excessive erythrocytosis in high altitude Peru.
Painschab MS; Malpartida GE; Dávila-Roman VG; Gilman RH; Kolb TM; León-Velarde F; Miranda JJ; Checkley W
High Alt Med Biol; 2015 Mar; 16(1):26-33. PubMed ID: 25760230
[TBL] [Abstract][Full Text] [Related]
17. Prognostic values of pathologic findings and hypoxia markers in 21 patients with salivary duct carcinoma.
Roh JL; Cho KJ; Kwon GY; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2008 Jun; 97(7):596-600. PubMed ID: 18449879
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma: a Southern China Urology Cancer Consortium Trial.
Xie M; He CS; Huang JK; Lin QZ
Eur J Cancer; 2015 Mar; 51(5):595-603. PubMed ID: 25618828
[TBL] [Abstract][Full Text] [Related]
19. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
